Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.190
-0.060 (-2.67%)
At close: Apr 28, 2026, 4:00 PM EDT
2.190
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:45 PM EDT
Allogene Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 753 | 308 | 447 | 540 | 907 | 2,126 | |
| Market Cap Growth | 153.08% | -31.06% | -17.32% | -40.45% | -57.34% | -39.95% | |
| Enterprise Value | 595 | 141 | 248 | 171 | 457 | 1,697 | |
| Last Close Price | 2.25 | 1.37 | 2.13 | 3.21 | 6.29 | 14.92 | |
| PS Ratio | - | - | 20300.07 | 5685.98 | 5814.63 | 18.64 | |
| PB Ratio | 1.76 | 1.05 | 1.06 | 1.06 | 1.36 | 2.32 | |
| P/TBV Ratio | 2.60 | 1.05 | 1.06 | 1.06 | 1.36 | 2.32 | |
| EV/Sales Ratio | - | - | 11252.80 | 1803.61 | 2931.99 | 14.87 | |
| Debt / Equity Ratio | 0.28 | 0.28 | 0.22 | 0.19 | 0.15 | 0.08 | |
| Net Debt / Equity Ratio | -0.57 | -0.57 | -0.48 | -0.69 | -0.62 | -0.42 | |
| Net Debt / EBITDA Ratio | 0.86 | 0.86 | 0.83 | 1.18 | 1.30 | 2.26 | |
| Net Debt / FCF Ratio | 1.12 | 1.12 | 1.00 | 1.48 | 1.84 | 1.86 | |
| Asset Turnover | - | - | 0 | 0 | 0 | 0.10 | |
| Quick Ratio | 7.74 | 7.74 | 8.29 | 12.15 | 9.69 | 9.62 | |
| Current Ratio | 7.93 | 7.93 | 8.54 | 12.38 | 9.84 | 9.78 | |
| Return on Equity (ROE) | -53.42% | -53.42% | -55.13% | -55.51% | -43.00% | -18.24% | |
| Return on Assets (ROA) | -26.82% | -26.82% | -27.01% | -26.84% | -22.55% | -9.94% | |
| Return on Capital Employed (ROCE) | -54.00% | -54.00% | -50.20% | -51.90% | -43.70% | -18.20% | |
| Earnings Yield | -25.05% | -62.00% | -57.68% | -60.59% | -37.53% | -8.56% | |
| FCF Yield | -19.64% | -48.60% | -45.01% | -44.29% | -24.88% | -9.70% | |
| Buyback Yield / Dilution | -13.25% | -13.25% | -24.14% | -9.63% | -5.39% | -12.84% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.